NARA Discovery
Article Details
← Back to Search Results
Journal Article

Advances and challenges in cancer treatment and nutraceutical prevention: the possible role of dietary phenols in BRCA regulation

Haroon Khan; Fabiana Labanca; Hammad Ullah; Yaseen Hussain; Nikolay T. Tzvetkov; Esra Küpeli Akkol; Luigi Milella
Phytochemistry Reviews · Vol. 21, Issue 2 · pp. 385-400 · 2022

Abstract

Over the years, the attention towards the role of phytochemicals in dietary natural products in reducing the risk of developing cancer is rising. Cancer is the second primary cause of mortality worldwide. The current therapeutic options for cancer treatment are surgical excision, immunotherapy, chemotherapy, and radiotherapy. Unfortunately, in case of metastases or chemoresistance, the treatment options become very limited. Despite the advances in medical and pharmaceutical sciences, the impact of available treatments on survival is not satisfactory. Recently, natural products are a great deal of interest as potential anti-cancer agents. Among them, phenolic compounds have gained a great deal of interest, thanks to their anti-cancer activity. The present review focuses on the suppression of cancer by targeting BRCA gene expression using dietary polyphenols, as well as the clinical aspects of polyphenolic agents in cancer therapy. They regulate specific key processes involved in cancer progression and modulate the expression of oncogenic proteins, like p27, p21, and p53, which may lead to apoptosis, cell cycle arrest, inhibition of cell proliferation, and, consequently, cancer suppression. Thus, one of the mechanisms underlying the anti-cancer activity of phenolics involves the regulation of tumor suppressor genes. Among them, the BRCA genes, with the two forms ( BRCA-1 and BRCA-2 ), play a pivotal role in cancer protection and prevention. BRCA germline mutations are associated with an increased risk of developing several types of cancers, including ovarian, breast, and prostate cancers. BRCA genes also play a key role in the sensitivity and response of cancer cells to specific pharmacological treatments. As the importance of BRCA-1 and BRCA-2 in reducing cancer invasiveness, repairing DNA damages, oncosoppression, and cell cycle checkpoint, their regulation by natural molecules has been examined.

Bibliographic Information

JournalPhytochemistry Reviews
PublisherSpringer
Publication Date2022-04-01
Publication Year2022
Volume21
Issue2
Pages385-400
Document TypeJournal Article
Print ISSN1568-7767
eISSN1572-980X
DOI10.1007/s11101-021-09771-3

Access Information

NARA Access Coverage2002-01-01~Current
Journal Homepagehttps://www.springer.com/journal/11101
Publisher PageOpen Publisher Page
Full-text access depends on NARA's subscribed coverage and institutional access.